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Article 8

researchbr iefs
Penn Launches Institute for
Regenerative Medicine

Agent Orange Chemical Attacks
Mitochondria to Cause Cancer

In November 2007 Penn announced the launch of the
cross-disciplinary Institute for Regenerative Medicine to
investigate and harness the therapeutic potential of stem
cells in treating cancer, diabetes, cardiovascular disease,
degenerative diseases, wound healing and aging. Ralph L.
Brinster,V’60, Richard King Mellon Professor of
Reproductive Physiology at Penn Vet, and Dr. Jonathan A.
Epstein,William Wikoff Smith Chair in Cardiovascular
Research and chair of Penn Medicine’s Department of
Cell and Developmental Biology, will head the Institute.
The Institute will draw on existing Penn programs in
basic cell and organ biology, extensive animal modeling
opportunities, practical and experiential expertise in tissue
engineering, innovative translational research programs and
ready access to pediatric and adult patients.

Dr. Narayan Avadhani, chair of Penn Vet’s Department
of Animal Biology, led a team of School researchers that
demonstrated the process by which the cancer-causing
chemical dioxin attacks cellular machinery, disrupts normal
cellular function and promotes tumor progression.The
team discovered that mitochondria, the cellular subunits
that convert oxygen and nutrients into cellular fuel, are
the target of tetrachlorobenzodioxin, or TCDD.The
research showed that TCDD induces mitochondria-tonucleus stress signaling, which in turn induces expression
of cell nucleus genes associated with tumor promotion
and metastasis.TCDD, the most toxic compound in the
dioxin family, is a by-product during waste incineration
and paper, chemical and pesticide manufacturing. It was
the toxic ingredient in Agent Orange and closed the Love
Canal in Niagara Falls.The public health impact of dioxin,
according to the Environmental Protection Agency,
compares to that of the pesticide DDT.
The study appeared in the December 17, 2007 issue of
the Proceedings of the National Academy of Sciences. Other
Penn Vet researchers include Drs. Gopa Biswas, Satish
Srinivasan and Hindupur Anandatheerthavarada.
Research was supported by the National Cancer Institute
and the National Institutes of Health.

Protein Interactions in ImmuneSystem Response Identified
A team of Penn Vet researchers, led by Dr. Christopher
Hunter, chair of the Department of Pathobiology, has
identified protein interactions involved in the immune
system process that fights infection, yet, in certain
inflammatory
diseases, attacks
friendly tissue.
This signaling
protein,
Interleukin 10
(IL-10), plays an
important role
in regulating the
White and red blood cells.
balance between
the protective
white blood, or T, cell response and one that is
pathological and out of control.
While IL-10 is recognized as a major anti-inflammatory
factor, what leads to its production has been poorly understood. According to the findings, messenger proteins
Interleukin 27, or a combination of Interleukin 6 and
another type of messenger molecule called transforming
growth factor beta, induce production of IL-10.This suggests that modulating these messenger molecules could
increase IL-10 concentrations that temper overactive
immune responses.The study sheds light on the immunesystem response and may provide directed means to intervene in severe autoimmune disease.
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One Shot of Gene Therapy Spreads
Through Brain in Animal Study
In the September 12, 2007 issue of the Journal of
Neuroscience, John H. Wolfe,V’82 GR’86, professor of
pathology and medical genetics and director of the Walter
Flato Goodman Center for Comparative Medical Genetics,
and researchers from the Children’s Hospital of Philadelphia
show that, in a mouse study, a single gene therapy injection
to one location in the brain can deliver a beneficial gene
throughout the brain, provided the initial injection site is
sufficiently well connected. If these results can be replicated
in humans, it could prove a potent weapon against
neurological disorders such as Tay-Sachs disease.The
researchers targeted a well-connected area of the brain
using a neutralized virus for a delivery vehicle.The virus
was carried along neural pathways throughout the brain,
delivering the enzyme-producing gene. One benefit was
that each corrected cell produced a “sphere of correction”
where it provided the enzymes to neighboring cells as well.
Given the results, the possibility exists for future cases to
need a limited number of treatments for a full recovery, but
the possible use of this treatment on humans is years away.

researchbr iefs
Researchers Learn More about
How Herpes Virus Invades Cells
Penn researchers have uncovered an important step in
how herpes simplex virus (HSV-1) uses cooperating
proteins on its outer coat to gain entry into healthy cells
and infect them.The researchers believe they have
demonstrated the effectiveness of monitoring these protein
interactions using biomolecular complementation.
Participating in the study were Dr. Roselyn Eisenberg,
professor of microbiology at Penn Vet; J. Charles
Whitbeck, GR’93, and Brigid Reilly,V’09, of the
Department of Pathobiology at Penn Vet; Gary Cohen,
professor of microbiology at Penn Dental; and Doina
Atanasiu and Tina M. Cairns of the Department of
Microbiology at Penn Dental.The study was supported by
the National Institute of Allergy and Infectious Diseases
and the Merck Summer Research Fellowship Program at
Penn Vet.
The findings, published in the Proceedings of the National
Academy of Sciences, provide a better understanding of the
mechanism that viruses use to conquer healthy cells.

Silencing Small but
Mighty Cancer Inhibitors
Researchers from Penn Vet and Johns Hopkins University
have uncovered another reason why one of the most
commonly activated proteins in cancer is so dangerous. As
reported in Nature Genetics in December 2007, the Myc
protein can stop production of at least 13 microRNAs,
small pieces of nucleic acid that help control which genes
are turned on and off.
Also, in several instances, re-introducing repressed
microRNAs into Myc-containing cancer cells suppressed
tumor growth in mice, raising the possibility that a type of
gene-therapy approach could be effective for treating certain cancers.
From Penn Vet were Dr. Andrei ThomasTikhonenko, associate professor of pathology, and Dr.
Duonan Yu, from the Department of Pathobiology.The
research was funded by the National Institutes of Health.

Students recently participated in Penn Vet
Student Research Day; abstracts from their
presentations can be found at
www.vet.upenn.edu/research/students.

Work by Penn Vet
Researchers Selected for
Faculty of 1000 Biology
The paper “The Sugar Glider (Petaurus breviceps): A
Laboratory Host for the Nematode Parastrongyloides trichosuri”—coauthored by the Department of
Pathobiology’s Dr.
Thomas J. Nolan,
Sugar glider.
adjunct associate professor of parasitology,
and professors Dr.
Gerhard A. Schad,
HON’77, and Dr.
James B. Lok, along
with X. Zhu, J. Cole
and W. Grant—was
selected for Faculty of
1000 Biology. Launched in 2002, Faculty of 1000 Biology
is an award-winning on-line service that highlights and
evaluates the most interesting papers published in the biological sciences, based on recommendations of more than
2,000 of the world’s top researchers.The paper appeared
in the October 2007 issue of the Journal of Parasitology.

Oxygen Levels Affect Immune
System Response
Dr. Cindy Otto, associate professor of critical care, was
part of a team of researchers that discovered a signaling
pathway involved in the body’s responses to infections and
other damaging stimuli. Drugs or other treatments that
alter this signaling potentially could help either improve
the effectiveness of the immune response or reduce the
damage that results when the immune system gets
overactive, as in autoimmune diseases or sepsis
(overwhelming infection).The team found that activated
macrophages immediately stop making nitric oxide (NO)
when oxygen is removed, and this effect is reversed as
soon as oxygen is reintroduced into the environment.This
rapid and reversible control of NO production occurs at
levels of oxygen found in many disease states, suggesting
that regulation of NO production by oxygen may be
important in patients.
The findings were published in the article “Physiologic
and Hypoxic O2 Tensions Rapidly Regulate NO
Production by Stimulated Macrophages,” which appears
in the on-line version of the American Journal of
Physiology–Cell Physiology.
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